CREDIT ACTIVITY · 2026
IoTech Solutions Joins Cyberview Living Lab Accelerator Cohort 21
IoTech Solutions took a pivotal step toward commercial scale in June 2026 when it was selected to join Cohort 21 of the Cyberview Living Lab Accelerator (CLLA), Malaysia's first and longest-running startup accelerator, operated by Cyberview Sdn Bhd from its Cyberjaya innovation hub, bringing its flagship ARIVAAN MediGuard non-contact health-screening platform into a focused four-month equity-free programme that provides more than RM100,000 in value-added services including mentoring, industry access, investor networking, cloud credits, and eligibility for Cyberview's Pilot Project Incentive, with IoTech presenting among 23 high-impact Malaysian startups at the CLLA Cohort 21 Solution Showcase 2.0 on 21 May 2026 within the Smart Healthcare & Wellness track.
The ARIVAAN MediGuard ecosystem itself is a comprehensive AI-driven health-screening solution comprising the MediGuard Rover, an autonomous mobile screening unit that brings healthcare directly to patients, the MediGuard Kiosk, a fixed self-service screening station for hospitals, clinics, and community locations, and the Aetherion AI Platform, a multilingual clinical reasoning engine supporting nine languages through agentic AI, retrieval architectures, medical knowledge graphs, and an edge-fog-cloud computing stack, all powered by a 12-modality sensor suite that captures vital signs and environmental indicators completely without physical contact, making screening faster, more hygienic, and more accessible across clinics, eldercare facilities, and community healthcare settings
Crucially, IoTech entered the accelerator with validated commercial traction already in place through a paid clinical pilot agreement with Oceana Clinic, structured across two implementation phases during 2026 that serve as the primary validation milestone for ARIVAAN MediGuard before wider commercial rollout, and as Founder and CEO Ir. Narendran Ramasenderan noted, being part of CLLA Cohort 21 places IoTech exactly where it needs to be—surrounded by Malaysia's strongest deeptech founders with direct access to the pilots, mentors, and investors who can take the platform from validation to nationwide impact; with the CLLA programme as a launchpad, IoTech Solutions is now focused on completing its Oceana Clinic pilot phases, expanding clinical deployment opportunities, and advancing its current seed fundraising efforts, with the ultimate goal of scaling the ARIVAAN MediGuard ecosystem across Malaysia and into regional healthcare markets, reinforcing the company's trajectory from award-winning innovator to commercially deployed deeptech venture ready to make health screening more accessible, intelligent, and impactful for communities everywhere.
